Recent literature reviews have reported that an overall, clinically typical form of PD with early onset, slow progression, and excellent response to levodopa treatment is frequently associated with dystonia and dyskinesia in patients with PARKIN mutations (Grünewald et al., 2013; Kasten et al., 2018). The gene discussed is PRKN; the disease is drug-induced dyskinesia.